Tenax Therapeutics (TENX) Preferred Dividend Payments (2013 - 2014)
Tenax Therapeutics (TENX) posted quarterly Preferred Dividend Payments of $11.5 million for Q2 2014, up 1105.08% year-over-year from $958071.0 in Q2 2013, and up 1153.59% on a QoQ basis from -$1.1 million in Q1 2014.
Tenax Therapeutics (TENX) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Tenax Therapeutics has reported Preferred Dividend Payments for 2 years, with the latest figure at $11.5 million in Q2 2014.
- Preferred Dividend Payments for Q2 2014 came in at $11.5 million, up 1105.08% year-over-year; the trailing twelve-month figure through Jan 2015 was $11.5 million (up 341.33% YoY), and the FY2018 annual result was $7.3 million, changed N/A from the prior year.
- Preferred Dividend Payments improved to $11.5 million in Q2 2014, from -$1.1 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $11.5 million in Q2 2014 and troughed at -$2.6 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2014 | 11.55 Mn |
| Jan 31, 2014 | -1.10 Mn |
| Oct 31, 2013 | -2.55 Mn |
| Jul 31, 2013 | -2.09 Mn |
| Apr 30, 2013 | 958,071.00 |